Literature DB >> 16741940

Association analyses suggest GPR24 as a shared susceptibility gene for bipolar affective disorder and schizophrenia.

J E Severinsen1, T D Als, H Binderup, T A Kruse, A G Wang, M Vang, W J Muir, D H R Blackwood, O Mors, A D Børglum.   

Abstract

Linkage analyses suggest that chromosome 22q12-13 may harbor a shared susceptibility locus for bipolar affective disorder (BPD) and schizophrenia (SZ). In a study of a sample from the Faeroe Islands we have previously reported association between both disorders and microsatellite markers in a 3.6 cM segment on 22q13. The present study investigated three candidate genes located in this segment: GPR24, ADSL, and ST13. Nine SNPs located in these genes and one microsatellite marker (D22S279) were applied in an association analysis of two samples: an extension of the previously analyzed Faeroese sample comprising 28 distantly related cases (17 BPD, 11 SZ subjects) and 44 controls, and a Scottish sample including 162 patients with BPD, 103 with SZ, and 200 controls. In both samples significant associations were observed in both disorders with predominantly GPR24 SNPs and haplotypes. In the Faeroese sample overall P-values of 0.0009, 0.0054, and 0.0023 were found for haplotypes in BPD, SZ, and combined cases, respectively, and in the Scottish sample overall P-values of 0.0003, 0.0005, and 0.016 were observed for similar groupings. Specific haplotypes showed associations with lowest P-values of 7 x 10(-5) and 0.0006 in the combined group of cases from the Faeroe Islands and Scotland, respectively. The G protein-coupled receptor 24 encoded by GPR24 binds melanin-concentrating hormone (MCH) and has been implicated with feeding behavior, energy metabolism, and regulation of stress and mood. To our knowledge this is the first study reporting association between GPR24 and BPD and SZ, suggesting that GPR24 variants may confer susceptibility to both disorders. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16741940     DOI: 10.1002/ajmg.b.30335

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  10 in total

1.  A genome-wide study of panic disorder suggests the amiloride-sensitive cation channel 1 as a candidate gene.

Authors:  Noomi Gregersen; Hans A Dahl; Henriette N Buttenschøn; Mette Nyegaard; Anne Hedemand; Thomas D Als; August G Wang; Sofus Joensen; David Pd Woldbye; Pernille Koefoed; Ann S Kristensen; Torben A Kruse; Anders D Børglum; Ole Mors
Journal:  Eur J Hum Genet       Date:  2011-08-03       Impact factor: 4.246

2.  Decreased muscarinic receptor binding in the frontal cortex of bipolar disorder and major depressive disorder subjects.

Authors:  A S Gibbons; E Scarr; C McLean; S Sundram; B Dean
Journal:  J Affect Disord       Date:  2008-12-21       Impact factor: 4.839

3.  Two complex genotypes relevant to the kynurenine pathway and melanotropin function show association with schizophrenia and bipolar disorder.

Authors:  Christine L Miller; Peter Murakami; Ingo Ruczinski; Randal G Ross; Melissa Sinkus; Bernadette Sullivan; Sherry Leonard
Journal:  Schizophr Res       Date:  2009-06-06       Impact factor: 4.939

4.  The melanin-concentrating hormone (MCH) system modulates behaviors associated with psychiatric disorders.

Authors:  Shinjae Chung; Michel M M Verheij; Peter Hesseling; Ruben W M van Vugt; Mahalah Buell; James D Belluzzi; Mark A Geyer; Gerard J M Martens; Olivier Civelli
Journal:  PLoS One       Date:  2011-07-19       Impact factor: 3.240

5.  Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder.

Authors:  Emma L Dempster; Ruth Pidsley; Leonard C Schalkwyk; Sheena Owens; Anna Georgiades; Fergus Kane; Sridevi Kalidindi; Marco Picchioni; Eugenia Kravariti; Timothea Toulopoulou; Robin M Murray; Jonathan Mill
Journal:  Hum Mol Genet       Date:  2011-09-09       Impact factor: 6.150

6.  Increased expression of retinoic acid-induced gene 1 in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression.

Authors:  Johannes Haybaeck; Magdalena Postruznik; Christine L Miller; Jeannette R Dulay; Ida C Llenos; Serge Weis
Journal:  Neuropsychiatr Dis Treat       Date:  2015-02-04       Impact factor: 2.570

7.  Melanin Concentrating Hormone Signaling Deficits in Schizophrenia: Association With Memory and Social Impairments and Abnormal Sensorimotor Gating.

Authors:  Marquis P Vawter; Anton Schulmann; Lamees Alhassen; Wedad Alhassen; Abdul Rezzak Hamzeh; Jasmine Sakr; Lucas Pauluk; Ryan Yoshimura; Xuejie Wang; Qi Dai; Nayna Sanathara; Olivier Civelli; Amal Alachkar
Journal:  Int J Neuropsychopharmacol       Date:  2020-03-10       Impact factor: 5.176

8.  Melanin concentrating hormone modulates oxytocin-mediated marble burying.

Authors:  Nayna M Sanathara; Celia Garau; Amal Alachkar; Lien Wang; Zhiwei Wang; Katsuhiko Nishimori; Xiangmin Xu; Olivier Civelli
Journal:  Neuropharmacology       Date:  2017-09-06       Impact factor: 5.273

9.  Evidence for phenotypic plasticity in response to photic cues and the connection with genes of risk in schizophrenia.

Authors:  Christine L Miller
Journal:  Front Behav Neurosci       Date:  2013-07-09       Impact factor: 3.558

Review 10.  The Epigenetics of Psychosis: A Structured Review with Representative Loci.

Authors:  Christine L Miller
Journal:  Biomedicines       Date:  2022-02-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.